NASDAQ:LJPC
Delisted
La Jolla Pharmaceutical Company Stock News
$6.22
+0 (+0%)
At Close: Jan 27, 2023
Un estudio encuentra que un 40% de personas que no fueron infectadas por SARS-Cov-2 tienen células T del sistema inmune que podrían combatir el COVID-19.
Share trading: the choices, the charges, the risks
04:30am, Tuesday, 19'th May 2020
Stock market flutters should never be made lightly
Sproutly Announces a Business Transformation Plan and Investment by Infusion Biosciences
12:00am, Friday, 15'th May 2020
Sproutly Canada, Inc. (CSE:SPR) (OTCQB:SRUTF) (FSE:38G) (“Sproutly” or the “Company”) announces a business transformation plan that will shift the Com
CRH Medical Corporation (CRHM) CEO Tushar Ramani on Q1 2020 Results - Earnings Call Transcript
04:12pm, Wednesday, 13'th May 2020
CRH Medical Corporation (NYSEMKT:CRHM) Q1 2020 Results Conference Call May 13, 2020 08:30 AM ET Company Participants Tushar Ramani - Chief Executive Office Rich
AcelRx Pharmaceuticals, Inc. (ACRX) CEO Vince Angotti on Q1 2020 Results - Earnings Call Transcript
03:13am, Tuesday, 12'th May 2020
AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) Q1 2020 Results Earnings Conference Call May 11, 2020, 04:30 PM ET Company Participants Raffi Asadorian - CFO Vince A
La Jolla's Path Forward
11:49pm, Friday, 08'th May 2020
Giapreza sales continue to grow at a rather muted speed which may be due to a combination of market size limitations, pricing, and lack of clear benefits. There
European shares end higher on US-China talks, earnings optimism
05:32pm, Friday, 08'th May 2020
Markets report: Basic resources sector best weekly performer
Tetraphase: A Bidding War Shareholders Shouldn't Wait Around For
03:09pm, Friday, 08'th May 2020
Shares in Tetraphase sky-rocketed yesterday after La Jolla announced a non-binding takeover proposal. Tetraphase had already agreed to be bought by AcelRx in Ma
Bidding War Sends Tetraphase Shares Soaring
04:55pm, Thursday, 07'th May 2020
Shares of nano-cap Tetraphase Pharmaceuticals Inc (NASDAQ: TTPH), which have never really recovered from a steep sell-off triggered by an adverse clinical readout in late 2015, are surging Thursday af
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
